Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
N. Lewit, S. Kol, D. Manor & J. Itskovitz-Eldor. (1995) The use of GnRH analogs for induction of the preovulatory gonadotropin surge in assisted reproduction and prevention of the ovarian hyperstimulation syndrome. Gynecological Endocrinology 9:sup4, pages 13-17.
Read now
Read now
J. Balasch, R. Tur, M. Creus, R. Buxaderas, F. Fábregues, J. L. Ballescá, P. N. Barri & J. A. Vanell. (1994) Triggering of ovulation by a gonadotropin releasing hormone agonist in gonadotropin-stimulated cycles for prevention of ovarian hyperstimulation syndrome and multiple pregnancy. Gynecological Endocrinology 8:1, pages 7-12.
Read now
Read now
Articles from other publishers (30)
Chaitanya Nagori, Sonal Panchal, Swati Yadav, Sushma Nadagouda & Manish Thakker. (2022) Comparative Study of Dual Trigger vs hCG Trigger in Intrauterine Insemination Cycles. Donald School Journal of Ultrasound in Obstetrics and Gynecology 16:4, pages 266-271.
Crossref
Crossref
Xue-Fei Li, Qiao-Feng Wang, Qi-Qi He, Xue-Jiao Wang, Xing-Yu LV, Xiao-Jun Tang, Zhao-Hui Zhong, Yu-Bin Ding & Qi Wan. (2022) Low LH level does not indicate poor IVF cycle outcomes with GnRh-a single trigger: a retrospective analysis. BMC Pregnancy and Childbirth 22:1.
Crossref
Crossref
Maitha M. Alhajeri, Rayyah R. Alkhanjari, Rawad Hodeify, Ali Khraibi & Hamdan Hamdan. (2022) Neurotransmitters, neuropeptides and calcium in oocyte maturation and early development. Frontiers in Cell and Developmental Biology 10.
Crossref
Crossref
Anastasia Salameh, Sara Faour & Johnny Awwad. 2022. Ovarian Stimulation. Ovarian Stimulation
282
289
.
Ling Deng, Xue-lan Li, De-sheng Ye, Christophe Blockeel, Xing-yu Zhou, Shi-ling Chen & Xin Chen. (2019) A Second Dose of GnRHa in Combination with Luteal GnRH Antagonist May Eliminate Ovarian Hyperstimulation Syndrome in Women with ≥30 Follicles Measuring ≥11 mm in Diameter on Trigger Day and/or Pre-trigger Peak Estradiol Exceeding 10 000 pg/mL. Current Medical Science 39:2, pages 278-284.
Crossref
Crossref
Minh Tam Le, Dac Nguyen Nguyen, Jessica Zolton, Vu Quoc Huy Nguyen, Quang Vinh Truong, Ngoc Thanh Cao, Alan Decherney & Micah J. Hill. (2019) GnRH Agonist versus hCG Trigger in Ovulation Induction with Intrauterine Insemination: A Randomized Controlled Trial. International Journal of Endocrinology 2019, pages 1-6.
Crossref
Crossref
Hady El Hachem, Charlotte Sonigo, Julie Benard, Marion Presse, Christophe Sifer, Nathalie Sermondade & Michael Grynberg. (2018) Comparison of GnRH agonist and hCG for priming in vitro maturation cycles in cancer patients undergoing urgent fertility preservation. PLOS ONE 13:12, pages e0208576.
Crossref
Crossref
Ashraf Alleyassin, Marzieh Ghasemi, Marzieh Aghahosseini, Leila Safdarian, Fatemeh Sarvi, Amir Almasi-Hashiani, Sedigheh Hosseinimousa, Aida Najafian & Arezoo Esmailzadeh. (2018) Final oocyte maturation with a dual trigger compared to human chorionic gonadotropin trigger in antagonist co-treated cycles: A randomized clinical trial. Middle East Fertility Society Journal 23:3, pages 199-204.
Crossref
Crossref
Shikha Bathwal, Astha Chakravarty, Sunita Sharma, Soma Singh, Indranil Saha & Baidyanath Chakravarty. (2018) Efficacy of GnRH agonist trigger in women having history of follicular–endometrial asynchrony with clomiphene/IUI cycles in unexplained infertility. Archives of Gynecology and Obstetrics 298:2, pages 427-432.
Crossref
Crossref
Mustafa Bahceci & Fazilet Kubra Boynukalın. 2018. Encyclopedia of Reproduction. Encyclopedia of Reproduction
263
267
.
Basil C. Tarlatzis, Julia Bosdou & Stratis Kolibianakis. 2017. Complications and Outcomes of Assisted Reproduction. Complications and Outcomes of Assisted Reproduction
149
163
.
Lawrence Engmann, Claudio Benadiva & Peter Humaidan. (2016) GnRH agonist trigger for the induction of oocyte maturation in GnRH antagonist IVF cycles: a SWOT analysis. Reproductive BioMedicine Online 32:3, pages 274-285.
Crossref
Crossref
Ernesto Bosch, Elena Labarta, Efstratios Kolibianakis, Mitchell Rosen & David Meldrum. (2016) Regimen of ovarian stimulation affects oocyte and therefore embryo quality. Fertility and Sterility 105:3, pages 560-570.
Crossref
Crossref
Robert F. Casper. (2015) Basic understanding of gonadotropin-releasing hormone–agonist triggering. Fertility and Sterility 103:4, pages 867-869.
Crossref
Crossref
Zalman Levine, Inna Berin & Daniel Navot. 2012. Textbook of Assisted Reproductive Techniques, Volume Two: Clinical Perspectives. Textbook of Assisted Reproductive Techniques, Volume Two: Clinical Perspectives
341
359
.
María Cerrillo, Alberto Pacheco, Sara Rodríguez, Raúl Gómez, Francisco Delgado, Antonio Pellicer & Juan A. Garcia-Velasco. (2011) Effect of GnRH agonist and hCG treatment on VEGF, angiopoietin-2, and VE-cadherin: trying to explain the link to ovarian hyperstimulation syndrome. Fertility and Sterility 95:8, pages 2517-2519.
Crossref
Crossref
Pasquale Sansone, Caterina Aurilio, Maria Caterina Pace, Raffaella Esposito, Maria Beatrice Passavanti, Vincenzo Pota, Leonardo Pace, Martina Gilda Pezzullo, Carlo Bulletti & Antonio Palagiano. (2011) Intensive care treatment of ovarian hyperstimulation syndrome (OHSS). Annals of the New York Academy of Sciences 1221:1, pages 109-118.
Crossref
Crossref
Juan A. Garcia-Velasco, Leticia Motta, Ana López, Mercedes Mayoral, Maria Cerrillo & Alberto Pacheco. (2010) Low-dose human chorionic gonadotropin versus estradiol/progesterone luteal phase support in gonadotropin-releasing hormone agonist–triggered assisted reproductive technique cycles: understanding a new approach. Fertility and Sterility 94:7, pages 2820-2823.
Crossref
Crossref
Hussein S. Qublan, Zakarya Beni-Merei, Mohamad Megdadi & Gassan Al-Quraan. (2008) Ovarian hyperstimulation syndrome following the sole administration of injectable gonadotropin-releasing hormone agonist (triptorelin) for the pituitary down-regulation and in vitro fertilization treatment: report of two cases. Archives of Gynecology and Obstetrics 279:2, pages 221-223.
Crossref
Crossref
Zalman Levine & Daniel Navot. 2008. Textbook of Assisted Reproductive Technologies. Textbook of Assisted Reproductive Technologies
759
772
.
Lawrence Engmann, Andrea DiLuigi, David Schmidt, John Nulsen, Donald Maier & Claudio Benadiva. (2008) The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study. Fertility and Sterility 89:1, pages 84-91.
Crossref
Crossref
I Parneix, J.C Emperaire, A Ruffie & P Parneix. (2001) Comparaison de différents protocoles de déclenchement de l’ovulation, par agonistes du GnRH et gonadotrophine chorionique. Gynécologie Obstétrique & Fertilité 29:2, pages 100-105.
Crossref
Crossref
Botros Rizk. 2009. Ovarian Hyperstimulation Syndrome. Ovarian Hyperstimulation Syndrome
130
199
.
William M. Buckett & Seang Lin Tan. (1998) 6 Use of luteinizing hormone releasing hormone agonists in polycystic ovary syndrome. Baillière's Clinical Obstetrics and Gynaecology 12:4, pages 593-606.
Crossref
Crossref
Edward E. Wallach, Zeev Shoham, Morey Schachter, Ernest Loumaye, Ariel Weissman, Michel MacNamee & Vaclav Insler. (1995) The luteinizing hormone surge—the final stage in ovulation induction: modern aspects of ovulation triggering. Fertility and Sterility 64:2, pages 237-251.
Crossref
Crossref
Antonio Lanzone, Anna Maria Fulghesu, Paola Villa, Costabile Guida, Maurizio Guido, Maria Carmela Nicoletti, Alessandro Caruso & Salvatore Mancuso. (1994) Gonadotropin-releasing hormone agonist versus human chorionic gonadotropin as a trigger of ovulation in polycystic ovarian disease gonadotropin hyperstimulated cycles. Fertility and Sterility 62:1, pages 35-41.
Crossref
Crossref
H.H. Goh. 1994.
135
176
.
R. Ron-El. (1993) 10 Complications of ovulation induction. Baillière's Clinical Obstetrics and Gynaecology 7:2, pages 435-453.
Crossref
Crossref
Edward E. Wallach, Daniel Navot, Paul A. Bergh & Neri Laufer. (1992) Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment. Fertility and Sterility 58:2, pages 249-261.
Crossref
Crossref
Shimon Segal & Robert F. Casper. (1992) Gonadotropin-releasing hormone agonist versus human chorionic gonadotropin for triggering follicular maturation in in vitro fertilization. Fertility and Sterility 57:6, pages 1254-1258.
Crossref
Crossref